(Date:6/18/2013)... 2013 Healthcare Solutions , ... Procura Management, today announced the appointment of Richard ... In this position, Leonardo will direct Healthcare Solutions’ ... strategic growth initiatives. , Recognized in the property ... Leonardo brings more than 20 years of experience ...
(Date:6/18/2013)... June 18, 2013 David Connett, DO, ... Family Medicine for the College of Osteopathic Medicine of ... has been elected president of the Osteopathic Medical ... Brown Jr. appointed Connett, a 1984 alumnus of COMP, ... recently elected Connett to the position during a conference ...
(Date:6/18/2013)... cells in the mammary gland appear to provide a ... in life, and the subsequent development of breast cancer, ... July 2013 issue of the journal Cancer Prevention ... be associated with an increased risk of certain types ... biology of social stress to cancer have been hard ...
(Date:6/18/2013)... a way to make phytosterol molecules from plants dispersible ... potentially opening the way to dramatic reductions in human ... new process and composition was issued on June 11. ... in animals are highly similar and when both are ... they mix in the gut of an animal, the ...
(Date:6/18/2013)... computer guided fitness training system using a person,s ... winners of the LeWeb,13 London Startup Competition, Europe,s ... startup company, Genetrainer, building on University of Bristol ... Pethica and Julian Gough, Professor of Bioinformatics in ... from over 350 startups to be one of ...
Breaking Medicine News(10 mins):Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 4Health News:Brandeis scientist invents anti-cholesterol process 2... , FRIDAY, Dec. 2 (HealthDay News) -- ... more than doubled in the United States between 1997 ... large increase of prescriptions written at outpatient clinics is ... Dorn, an assistant professor of medicine at the University ...
... University of Nevada, Reno and licensed through the University,s ... publication "Better World Report" for a remarkable second year ... advancement that has been licensed through IMMY, a diagnostics ... save the lives of hundreds of thousands of AIDS ...
... , FRIDAY, Dec. 2 (HealthDay News) -- Major depression and ... pregnant women and new mothers, a new study indicates. ... women are and what led up to these tragic events," ... medicine at the University of Michigan Medical School, said in ...
... The American Journal of Industrial Medicine recently published a ... at more than twice the rate of the general U.S. population ... the collapse of the WTC towers in 2001. Preliminary study results ... , Past studies have documented high rates of asthma symptoms among ...
... commercial stage private oncology company, has announced that prominent ... be the first to provide access to its Tumor ... of recurrent glioblastoma multiforme (GBM). GBM is a ... , The NovoTTF device, approved by the ...
... , FRIDAY, Dec. 2 (HealthDay News) -- ,Topical treatment ... be the first line of therapy for treating psoriasis ... from the National Psoriasis Foundation Medical Board based in ... because they cause no known adverse effects. Psoriasis, ...
Cached Medicine News:Health News:Depression, Partner Conflict Raise Suicide Risk for Pregnant Women, New Moms 2Health News:Asthma rates double for WTC first responders 2Health News:Asthma rates double for WTC first responders 3Health News:Novocure establishes initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields Therapy 2Health News:Novocure establishes initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields Therapy 3Health News:New Guidelines for Treating Psoriasis When Pregnant or Nursing 2(Date:6/17/2013)... AUSTIN, Texas , June 17, 2013 Hanger, ... new 5-year credit agreement that increases its senior secured ... from $400 million previously. The new credit agreement includes ... million term loan facility. The previous credit agreement was ... a $300 million term loan. Each new facility matures ...
(Date:6/17/2013)... BioMed Realty Trust, Inc. (NYSE: BMR ) today ... quarter 2013 dividend of $0.235 per share of common stock. ... per common share. The common stock dividend ... at the close of business on June 28, 2013. ... delivers optimal real estate solutions for biotechnology and pharmaceutical companies, ...
(Date:6/17/2013)... MOORESTOWN, N.J. , June 17, 2013 /PRNewswire-iReach/ ... of the company,s new X-4S pressure sensitive labeling ... most stringent speed and performance requirements that serialization ... close in, WLS is uniquely qualified to work ... partner in their serialization and track and trace ...
Breaking Medicine Technology:Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 2Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 3BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 2BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 3Weiler Labeling Introduces Serialization-Capable X-4S Labeling Head 2... Compound Achieves All Key Endpoints for Both ... 2007 /PRNewswire-FirstCall/ --,Indevus Pharmaceuticals, Inc. today announced ... for NEBIDO (testosterone,undecanoate), a long- acting injectable ... male hypogonadism which the,Company licensed from Bayer ...
... evaluating zonisamide SR as a novel component ... June 07, 2007 /PRNewswire-FirstCall/ -- Orexigen(TM),Therapeutics, Inc. ... of central nervous system disorders with an ... a Phase I trial evaluating,safety and pharmacokinetics ...
Cached Medicine Technology:Indevus Reports Positive Data From Phase III NEBIDO Trial 2Indevus Reports Positive Data From Phase III NEBIDO Trial 3Indevus Reports Positive Data From Phase III NEBIDO Trial 4Indevus Reports Positive Data From Phase III NEBIDO Trial 5Indevus Reports Positive Data From Phase III NEBIDO Trial 6OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 2OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 4Delicate Desmarres lid retractors, round serrated handle, very thin blades, polished finish, size 1....
2.0 mm cup , straight shaft, Flat handle, length 125.0 mm....
Size 4 - 2.25 mm...
The Storz Protege is an anterior segment unit only....
Medicine Products:Biology NavigationMedical Navigation